Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Immix Biopharma, Inc. (IMMX)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 16, 2026 | CORRESP | Neutral/Informational | Moderate | Immix Biopharma, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on January 9, 2026. They ar… | Read Filing EDGAR |
| Jan. 16, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has formally notified Immix Biopharma, Inc. that it will not review their registration statement filed on January 9, 2026. The letter emphasizes that the responsibility fo… | Read Filing EDGAR |
| Nov. 26, 2025 | CORRESP | Neutral/Informational | Moderate | Immix Biopharma, Inc. has submitted a request to the SEC for the acceleration of their Form S-3 Registration Statement, seeking to have it become effective on December 1, 2025, at… | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.